Corticosterone and immune cytokine characterization following environmental manipulation in female WKY rats

Behavioural Brain Research

Volumn 316, Issue , 2017, Pages 197-204

  Mileva, Guergana R ^a   Rooke, Jasmine ^a   Ismail, Nafissa ^a   Bielajew, Catherine ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Corticosterone; Cytokine; Depression; Hypothalamic pituitary adrenal axis; Immune response; Stress

Indexed keywords

CORTICOSTERONE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR;

ADRENAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE BLOOD LEVEL; DEPRESSION; ENDOCRINE FUNCTION; ENVIRONMENTAL ENRICHMENT; FEMALE; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; MENTAL STRESS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; STRAIN DIFFERENCE; SYMPTOM; WISTAR KYOTO RAT; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; ENVIRONMENT; ESTRUS CYCLE; GENE EXPRESSION REGULATION; PHYSIOLOGY; TIME FACTOR; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; CORTICOSTERONE; CYTOKINES; ENVIRONMENT; ESTROUS CYCLE; FEMALE; GENE EXPRESSION REGULATION; RATS; RATS, INBRED WKY; RATS, WISTAR; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 84986292033     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2016.09.004     Document Type: Article

References (68)

1. [1] Andrews, G., Brugha, T., Thase, M.E., Duffy, F.F., Rucci, P., Slade, T., Dimensionality and the category of major depressive episode. Int. J. Methods Psychiatr. Res. 16 (2007), 41–51, 10.1002/mpr.216.
2. [2] Connolly, K.R., Thase, M.E., If at first you donʼt succeed. Drugs 71 (2011), 43–64, 10.2165/11587620-000000000-00000.
3. [3] Lacasse, J.R., Leo, J., Serotonin and depression: a disconnect between the advertisements and the scientific literature. PLoS Med., 2, 2005, e392, 10.1371/journal.pmed.0020392.
4. [4] Checkley, S., The neuroendocrinology of depression and chronic stress. Br. Med. Bull. 52 (1996), 597–617, 10.3109/09540269609051552.
5. [5] Carroll, B.J., Cassidy, F., Naftolowitz, D., Tatham, N.E., Wilson, W.H., Iranmanesh, A., Liu, P.Y., Veldhuis, J.D., Pathophysiology of hypercortisolism in depression. Acta Psychiatr. Scand. 115 (2007), 90–103, 10.1111/j.1600-0447.2007.00967.x.
6. [6] Gillespie, C.F., Nemeroff, C.B., Hypercortisolemia and depression. Psychosom. Med. 67:Suppl. 1 (2005), S26–S28, 10.1097/01.psy.0000163456.22154.d2.
7. [7] Carroll, B.J., Iranmanesh, A., Keenan, D.M., Cassidy, F., Wilson, W.H., Veldhuis, J.D., Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback. Acta Psychiatr. Scand. 125 (2012), 478–491, 10.1111/j.1600-0447.2011.01821.x.
8. [8] Maripuu, M., Wikgren, M., Karling, P., Adolfsson, R., Norrback, K.F., Relative hypo- and hypercortisolism are both associated with depression and lower quality of life in bipolar disorder: a cross-sectional study. PLoS One, 9, 2014, 10.1371/journal.pone.0098682.
9. [9] Miller, A.H., Maletic, V., Raison, C.L., Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry. 65 (2009), 732–741, 10.1016/j.biopsych.2008.11.029 Inflammation.
10. [10] Vitkovic, L., Konsman, J., Bockaert, J., Dantzer, R., Homburger, V., Jacque, C., Cytokine signals propagate through the brain. Mol. Psychiatry. 5 (2000), 604–615 (accessed 09.06.16) www.nature.com/mp.
11. [11] Song, C., Halbreich, U., Han, C., Leonard, B.E., Luo, H., Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry 42 (2009), 182–188, 10.1055/s-0029-1202263.
12. [12] S. Layé, P. Parnet, E., Goujon, R. Dantzer, Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice, 1994. 10.1016/0169-328X(94)90197-X.
13. [13] Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008), 46–56, 10.1038/nrn2297.
14. [14] Kentner, A.C., Takeuchi, A., James, J.S., Miki, T., Seino, S., Hayley, S., Bielajew, C., The effects of rewarding ventral tegmental area stimulation and environmental enrichment on lipopolysaccharide-induced sickness behavior and cytokine expression in female rats. Brain Res. 1217 (2008), 50–61, 10.1016/j.brainres.2008.04.041.
15. [15] Stieglitz, J., Trumble, B.C., Thompson, M.E., Blackwell, A.D., Kaplan, H., Gurven, M., Depression as sickness behavior? A test of the host defense hypothesis in a high pathogen population. Brain. Behav. Immunol. 49 (2015), 130–139, 10.1016/j.bbi.2015.05.008.
16. [16] Dantzer, R., Cytokine, sickness behavior, and depression. Immunol. Allergy Clin. North Am. 29 (2009), 247–264, 10.1016/j.iac.2009.02.002.
17. [17] Dantzer, R., Cytokine-induced sickness behavior: mechanisms and implications. Ann. N. Y. Acad. Sci. 933 (2001), 222–234.
18. [18] Charlton, B.G., The malaise theory of depression: major depressive disorder is sickness behavior and antidepressants are analgesic. Med. Hypotheses 54 (2000), 126–130, 10.1054/mehy.1999.0986.
19. [19] Yirmiya, R., Endotoxin produces a depressive-like episode in rats. Brain Res. 711 (1996), 163–174 http://www.ncbi.nlm.nih.gov/pubmed/8680860 (accessed 24.08.16).
20. [20] Yirmiya, R., Pollak, Y., Barak, O., Avitsur, R., Ovadia, H., Bette, M., Weihe, E., Weidenfeld, J., Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 24 (2001), 531–544, 10.1016/S0893-133X(00)00226-8.
21. [21] de Paiva, V.N., Lima, S.N.P., Fernandes, M.M., Soncini, R., Andrade, C.A.F., Giusti-Paiva, A., Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice. Behav. Brain Res. 215 (2010), 146–151, 10.1016/j.bbr.2010.07.015.
22. [22] A. Danese, T.E. Moffitt, C.M. Pariante, A. Ambler, R. Poulton, A. Caspi, S. EM, W. CS, I. TR, E. DL, F.-S. N, B. LF, R. CL, R. PM, D. A, P. TW, P. CM, M. GE, P. MB, R. PM, P. TA, K. MA, W. CS, D. M, P. TW, C. A, R. LN, K. RC, D. J, F. DE, M. TE, C. E, R. LN, T. SE, P. R, S. A, D. P, F. VJ, A. RF, H. C, H. C, N. DJ, V. M, Elevated Inflammation Levels in Depressed Adults With a History of Childhood Maltreatment, Arch. Gen. Psychiatry. 65 (2008) 409. doi: 10.1001/archpsyc.65.4.409.
23. [23] Carek, P.J., Laibstain, S.E., Carek, S.M., Exercise for the treatment of depression and anxiety. Int. J. Psychiatry Med. 41 (2011), 15–28.
24. [24] Paykel, E.S., Life events, Social support and depression. Acta Psychiatr. Scand. 89 (1994), 50–58, 10.1111/j. 1600-0447.1994. tb05803.x.
25. [25] Rosenzweig, M.R., Bennett, E.L., Psychobiology of plasticity: effects of training and experience on brain and behavior. Behav. Brain Res. 78 (1996), 57–65 http://www.ncbi.nlm.nih.gov/pubmed/8793038 (accessed 24.08.16).
26. [26] Simpson, J., Kelly, J.P., The impact of environmental enrichment in laboratory rats-behavioural and neurochemical aspects. Behav. Brain Res., 2011, 10.1016/j.bbr.2011.04.002.
27. [27] Solinas, M., Thiriet, N., Chauvet, C., Jaber, M., Prevention and treatment of drug addiction by environmental enrichment. Prog. Neurobiol. 92 (2010), 572–592, 10.1016/j.pneurobio.2010.08.002.
28. [28] Bakos, J., Hlavacova, N., Rajman, M., Ondicova, K., Koros, C., Kitraki, E., Steinbusch, H.W.M., Jezova, D., Enriched environment influences hormonal status and hippocampal brain derived neurotrophic factor in a sex dependent manner. Neuroscience 164 (2009), 788–797, 10.1016/j.neuroscience.2009.08.054.
29. [29] Overstreet, D.H., Modeling depression in animal models. Methods Miol. 829 (2012), 125–144, 10.1007/978-1-61779-458-2_7.
30. [30] Okamato, K., Aoki, K., Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 27 (1963), 282–293 http://www.ncbi.nlm.nih.gov/pubmed/13939773 (accessed 15.06.16).
31. [31] Mileva, G.R., Bielajew, C., Environmental manipulation affects depressive-like behaviours in female Wistar-Kyoto rats. Behav. Brain Res. 293 (2015), 208–216, 10.1016/j.bbr.2015.07.035.
32. [32] Solberg, L.C., Olson, S.L., Turek, F.W., Redei, E., Altered hormone levels and circadian rhythm of activity in the WKY rat, a putative animal model of depression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001), R786–R794 http://www.ncbi.nlm.nih.gov/pubmed/11506993 (accessed 13.06.16).
33. [33] Paré, W.P., Stress ulcer susceptibility and depression in Wistar Kyoto (WKY) rats. Physiol. Behav. 46 (1989), 993–998 http://www.ncbi.nlm.nih.gov/pubmed/2634265 (accessed 13.06.16).
34. [34] Lahmame, A., del Arco, C., Pazos, A., Yritia, M., Armario, A., Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants?. Eur. J. Pharmacol. 337 (1997), 115–123 http://www.ncbi.nlm.nih.gov/pubmed/9430405 (accessed 13.06.16).
35. [35] Willner, P., Belzung, C., Treatment-resistant depression: are animal models of depression fit for purpose?. Psychopharmacology (Berl) 232 (2015), 3473–3495, 10.1007/s00213-015-4034-7.
36. [36] Beery, A.K., Zucker, I., Sex bias in neuroscience and biomedical research. Neurosci. Biobehav. Rev. 35 (2011), 565–572, 10.1016/j.neubiorev.2010.07.002.
37. [37] Zucker, I., Beery, A.K., Males still dominate animal studies. Nature, 465, 2010, 10.1038/465690a 690–690.
38. [38] Piccinelli, M., Wilkinson, G., Gender differences in depression. Critical review. Br. J. Psychiatry 177 (2000), 486–492.
39. [39] Mileva, G., Bielajew, C., Konkle, A.T.M., Sex differences in physiology and behaviour: the importance of hormones and rearing environment, in: estrous cycle physiol. Endocrinol. Role Breed. Reprod. Manag., 2013, 1–44.
40. [40] Clayton, J., Collins, F., NIH to balance sex in cell and animal studies. Nature 509 (2014), 282–288.
41. [41] Sengupta, P., The laboratory rat: relating its age with human's. Int. J. Prev. Med. 4 (2013), 624–630 http://www.ncbi.nlm.nih.gov/pubmed/23930179 (accessed 28.08.16).
42. [42] Marcondes, F.K., Bianchi, F.J., Tanno, A.P., Determination of the estrous cycle phases of rats: some helpful considerations. Braz. J. Biol. 62 (2002), 609–614 http://www.ncbi.nlm.nih.gov/pubmed/12659010 (accessed 29.06.16).
43. [43] Vahl, T.P., Ulrich-Lai, Y.M., Ostrander, M.M., Dolgas, C.M., Elfers, E.E., Seeley, R.J., D'Alessio, D.A., Herman, J.P., Comparative analysis of ACTH and corticosterone sampling methods in rats. Am. J. Physiol. Endocrinol. Metab. 289 (2005), E823–E828, 10.1152/ajpendo.00122.2005.
44. [44] Ferguson, G., Takane, Y., Statistical Analysis in Psychology and Education. 6th ed., 1989, McGraw-Hill, New York.
45. [45] Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S.Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., Sengul, A., Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin. Dev. Immunol., 2007(2007), 2007, 10.1155/2007/76396/76396.
46. [46] Liu, Y., Ho, R.C.-M., Mak, A., Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J. Affect. Disord. 139 (2012), 230–239, 10.1016/j.jad.2011.08.003.
47. [47] Tuglu, C., Kara, S.H., Caliyurt, O., Vardar, E., Abay, E., Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl). 170 (2003), 429–433, 10.1007/s00213-003-1566-z.
48. [48] Dunn, A.J., Cytokine activation of the HPA axis. Ann. N. Y. Acad. Sci. 917 (2000), 608–617, 10.1111/j.1749-6632.2000. tb05426.x.
49. [49] Uehara, A., Gottschall, P.E., Dahl, R.R., Arimura, A., Interleukin-1 stimulates acth release by an indirect action which requires endogenous corticotropin releasing factor. Endocrinology 121 (1987), 1580–1582, 10.1210/endo-121-4-1580.
50. [50] Armario, A., Gavaldà, A., Martí, J., Comparison of the behavioural and endocrine response to forced swimming stress in five inbred strains of rats. Psychoneuroendocrinology 20 (1995), 879–890, 10.1016/0306-4530(95)00018-6.
51. [51] Rittenhouse, P.A., López-Rubalcava, C., Stanwood, G.D., Lucki, I., Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat. Psychoneuroendocrinology 27 (2002), 303–318, 10.1016/s0306-4530(01)00052-x.
52. [52] De La Garza, R., Mahoney, J.J., A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression. Brain Res. 1021 (2004), 209–218, 10.1016/j.brainres.2004.06.052.
53. [53] Hatch, A.M., Wiberg, G.S., Zawidzka, Z., Cann, M., Airth, J.M., Grice, H.C., Isolation syndrome in the rat. Toxicol. Appl. Pharmacol. 7 (1965), 737–745.
54. [54] Heinrichs, S.C., Koob, G.F., Application of experimental stressors in laboratory rodents. Curr. Protoc. Neurosci., 2006, 10.1002/0471142301.ns0804s34 Chapter 8 (Unit8.4.).
55. [55] Himmerich, H., Binder, E.B., Künzel, H.E., Schuld, A., Lucae, S., Uhr, M., Pollmächer, T., Holsboer, F., Ising, M., Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Biol. Psychiatry. 60 (2006), 882–888, 10.1016/j.biopsych.2006.03.075.
56. [56] Berthold-Losleben, M., Himmerich, H., The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology. Curr. Neuropharmacol. 6 (2008), 193–202, 10.2174/157015908785777238.
57. [57] Williamson, L.L., Chao, A., Bilbo, S.D., Environmental enrichment alters glial antigen expression and neuroimmune function in the adult rat hippocampus. Brain Behav. Immunol. 26 (2012), 500–510, 10.1016/j.bbi.2012.01.003.
58. [58] Elenkov, I.J., Chrousos, G.P., Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol. Metab. 10 (1999), 359–368, 10.1016/S1043-2760(99)00188-5.
59. [59] Armstrong, L., Jordan, N., Millar, A., Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes. Thorax 51 (1996), 143–149 http://www.ncbi.nlm.nih.gov/pubmed/8711645 (accessed 09.06.16).
60. [60] Curtin, N.M., Mills, K.H.G., Connor, T.J., Psychological stress increases expression of IL-10 and its homolog IL-19 via beta-adrenoceptor activation: reversal by the anxiolytic chlordiazepoxide. Brain. Behav. Immunol. 23 (2009), 371–379, 10.1016/j.bbi.2008.12.010.
61. [61] Simmons, D.A., Broderick, P.A., Cytokines, stressors, and clinical depression: augmented adaptation responses underlie depression pathogenesis. Prog. Neuro Psychopharmacol. Biol. Psychiatry 29 (2005), 793–807, 10.1016/j.pnpbp.2005.03.009.
62. [62] Gullaiya, S., Nagar, A., Dubey, V., Singh, V., Kumar, A., Tiwari, P., Agrawal, S.S., Modulation of disease related immune events by demethoxycurcumin against autoimmune arthritis in rats. Biomed. Aging Pathol. 3 (2013), 7–13, 10.1016/j.biomag.2013.01.005.
63. [63] Silva, J.C.R., Rocha, M.F.G., Lima, A.A.M., Brito, G.A.C., de Menezes, D.B., Rao, V.S.N., Effects of pentoxifylline and nabumetone on the serum levels of IL-1β and TNFα in rats with adjuvant arthritis. Inflamm. Res. 49 (2000), 14–19, 10.1007/PL00000198.
64. [64] Straub, R.H., The complex role of estrogens in inflammation. Endocr. Rev. 28 (2007), 521–574, 10.1210/er.2007-0001.
65. [65] Gilmore, W., Weiner, L.P., Correale, J., Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 158 (1997), 446–551 http://www.ncbi.nlm.nih.gov/pubmed/8977221 (accessed 20.06.16).
66. [66] Mouihate, A., Chen, X., Pittman, Q.J., Interleukin-1beta fever in rats: gender difference and estrous cycle influence. Am. J. Physiol. 275 (1998), R1450–R1454 http://www.ncbi.nlm.nih.gov/pubmed/9791060 (accessed 20.26.16).
67. [67] Thaxton, J.E., Sharma, S., Interleukin-10: a multi-Faceted agent of pregnancy. Am. J. Reprod. Immunol 6 (2010), 482–491, 10.1111/j.1600-0897.2010.00810.x.
68. [68] Servatius, R.J., Jiao, X., Beck, K.D., Pang, K.C.H., Minor, T.R., Rapid avoidance acquisition in Wistar-Kyoto rats. Behav. Brain Res. 192 (2008), 191–197, 10.1016/j.bbr.2008.04.006.